SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
Heilbronn, Germany
About SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
During the past decade, SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
2011-04-01
2023-07-01
Active, not recruiting
1,545
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
According to Clinical.Site data, the most researched conditions in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen" are
"Brain and Central Nervous System Tumors" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Isocitrate Dehydrogenase" (1 trials), "Leukemia" (1 trials) and "Leukemia, Myeloid" (1 trials). Many other conditions were trialed in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen" in a lesser frequency.
Clinical Trials Intervention Types at SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
Most popular intervention types in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen" are "Drug" (5 trials), "Radiation" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (3 trials), "conventional surgery" (2 trials), "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials) and "ifosfamide" (2 trials). Other intervention names were less common.
Clinical Trials Genders at SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
The vast majority of trials in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen" are
6 trials for "All" genders.
Clinical Trials Status at SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
Currently, there are NaN active trials in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".